CL2018000201A1 - Potenciamiento de la respuesta inmunológica en especies acuáticas - Google Patents

Potenciamiento de la respuesta inmunológica en especies acuáticas

Info

Publication number
CL2018000201A1
CL2018000201A1 CL2018000201A CL2018000201A CL2018000201A1 CL 2018000201 A1 CL2018000201 A1 CL 2018000201A1 CL 2018000201 A CL2018000201 A CL 2018000201A CL 2018000201 A CL2018000201 A CL 2018000201A CL 2018000201 A1 CL2018000201 A1 CL 2018000201A1
Authority
CL
Chile
Prior art keywords
immune response
enhancement
aquatic species
subject
aquatic
Prior art date
Application number
CL2018000201A
Other languages
English (en)
Inventor
Christian Weiss
Nathalie C Simard
Jan Koesling
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of CL2018000201A1 publication Critical patent/CL2018000201A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55561CpG containing adjuvants; Oligonucleotide containing adjuvants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/10011Birnaviridae
    • C12N2720/10034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/10011Birnaviridae
    • C12N2720/10071Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

<p>LA PRESENTE INVENCIÓN EN FORMA GENERAL SE REFIERE A MÉTODOS PARA GENERAR UNA RESPUESTA INMUNOLÓGICA EN UN SUJETO DE UNA ESPECIE ACUÁTICA. EN PARTICULAR, UNA COMPOSICIÓN INMUNOMODULADORA SE UTILIZA PARA INDUCIR UNA RESPUESTA INMUNOLÓGICA A FIN DE POTENCIAR LA CAPACIDAD DEL SUJETO PARA COMBATIR LOS PATÓGENOS.</p>
CL2018000201A 2015-07-31 2018-01-24 Potenciamiento de la respuesta inmunológica en especies acuáticas CL2018000201A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562199840P 2015-07-31 2015-07-31

Publications (1)

Publication Number Publication Date
CL2018000201A1 true CL2018000201A1 (es) 2018-07-13

Family

ID=56571309

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2018000201A CL2018000201A1 (es) 2015-07-31 2018-01-24 Potenciamiento de la respuesta inmunológica en especies acuáticas

Country Status (13)

Country Link
US (1) US20190008952A1 (es)
EP (1) EP3328423B1 (es)
JP (1) JP2018521108A (es)
KR (1) KR20180035860A (es)
CN (1) CN108712912B (es)
AR (1) AR105539A1 (es)
AU (1) AU2016304343A1 (es)
CA (1) CA2994039A1 (es)
CL (1) CL2018000201A1 (es)
DK (1) DK3328423T3 (es)
IL (1) IL256947A (es)
TW (1) TWI733688B (es)
WO (1) WO2017021242A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI759317B (zh) 2016-07-26 2022-04-01 德商拜耳動物保健有限公司 牛物種中增加的生育力

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780448A (en) * 1995-11-07 1998-07-14 Ottawa Civic Hospital Loeb Research DNA-based vaccination of fish
CA2328602A1 (en) * 1998-05-06 1999-11-11 University Of Iowa Research Foundation Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides
US6693086B1 (en) * 1998-06-25 2004-02-17 National Jewish Medical And Research Center Systemic immune activation method using nucleic acid-lipid complexes
EP2257306B1 (en) * 2008-03-25 2014-05-07 Juvaris Biotherapeutics, Inc. Enhancement of an immune response by administration of a cationic lipid-dna complex (cldc)
WO2010130374A1 (en) * 2009-05-14 2010-11-18 Bayer Animal Health Gmbh Enhanced immune response in avian species
FR2964569B1 (fr) * 2010-09-10 2012-10-19 Ct De Cooperation Internationale En Rech Agronomique Pour Le Dev Cirad Nouveaux liposomes de vaccination genique
BR112013016231B1 (pt) * 2010-12-22 2021-03-23 Bayer Intellectual Property Gmbh Composição imunomoduladora para o tratamento de doença respiratória bovina
KR20160122849A (ko) * 2014-02-28 2016-10-24 바이엘 애니멀 헬스 게엠베하 면역자극성 플라스미드

Also Published As

Publication number Publication date
KR20180035860A (ko) 2018-04-06
DK3328423T3 (da) 2021-07-26
IL256947A (en) 2018-03-29
CN108712912B (zh) 2022-05-10
EP3328423B1 (en) 2021-05-26
TW201718006A (zh) 2017-06-01
AU2016304343A1 (en) 2018-02-08
CN108712912A (zh) 2018-10-26
US20190008952A1 (en) 2019-01-10
TWI733688B (zh) 2021-07-21
JP2018521108A (ja) 2018-08-02
WO2017021242A1 (en) 2017-02-09
CA2994039A1 (en) 2017-02-09
AR105539A1 (es) 2017-10-11
EP3328423A1 (en) 2018-06-06

Similar Documents

Publication Publication Date Title
FIC20240013I1 (fi) Lebrikitsumabi
EP3529149A4 (en) MULTICOPTER WITH ANGLED ROTORS
EP3745254C0 (en) QUANTUM RANDOM NUMBER GENERATORS
LT3149345T (lt) Būdas dviem objektams sujungti
HUE053760T2 (hu) SUV39h1-deficiens immunsejtek
EP3780389C0 (en) HIGH-PERFORMANCE RECONFIGURABLE VOLTAGE BUFFER
EP3317997C0 (en) QUANTUM TOKENS
EP3341839A4 (en) MIGRATION BETWEEN CPU CORE
EP3685682C0 (en) Oral rehydration composition
IL242971B (en) Ventricular far field reduction
DK3380120T3 (da) Immunstimulerende sammensætninger
CL2018000253A1 (es) Respuesta inmunitaria potenciada de las especies porcinas
EP3586869A4 (en) IMMUNOGENIC COMPOSITION TARGETED FOR S100A9
JP2015016294A5 (es)
EP3137649C0 (en) METALLIZATION OF SURFACES
IL250928A0 (en) Use of eliglutide to treat gastrointestinal mucosal inflammation including chemotherapy-induced diarrhea
HUE066530T2 (hu) PDS5A epitópok mint immunitás-indukálók
CL2018000201A1 (es) Potenciamiento de la respuesta inmunológica en especies acuáticas
KR20180084796A (ko) 열전기 발생기에서 사용하기 위한 반-호이슬러 화합물
DK3288143T3 (da) Skib med forbedret strømeffektivitet
ES1142182Y (es) Bomba cámara estanca alta eficiencia.
PT3126542T (pt) Pré-tratamento em duas etapas do alumínio, compreendendo mordentação e passivação
FR3042472B1 (fr) Engin flottant
HUE049401T2 (hu) Meddõ teljesítmény kezelés
TH1401007945A (th) ชุดระบายความร้อนแบบแท่งครีบเกลียวรอบ